Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: The Effective and Safety of Thalidomide in TI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the efficacy and safety of thalidomide in the treatment of thalassemia; the current status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: Xiao-Lin Yin | Conditions: Thalassemia | Phase 2 | Status: UNKNOWN